Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Brands
STZ
|
+$1.47B |
| 2 |
TC Energy
TRP
|
+$1.44B |
| 3 |
Broadcom
AVGO
|
+$1.37B |
| 4 |
Alcon
ALC
|
+$1.22B |
| 5 |
UnitedHealth
UNH
|
+$1.02B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.86B |
| 2 |
Verizon
VZ
|
+$1.9B |
| 3 |
Booking.com
BKNG
|
+$1.47B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.44B |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.37% |
| 2 | Technology | 16.98% |
| 3 | Consumer Discretionary | 12.52% |
| 4 | Communication Services | 11.95% |
| 5 | Industrials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Cisco
CSCO
$455B
| $209M | 0.07% |
3,817,453
-7,779,552
| -67% | -$430M |
|
202
Texas Roadhouse
TXRH
$14B
| $204M | 0.06% |
3,808,305
-481,862
| -11% | -$27.1M |
|
203
Xcel Energy
XEL
$49.5B
| $200M | 0.06% |
3,368,235
+3,092
| +0.1% | +$178K |
|
204
Intuit
INTU
$94.1B
| $200M | 0.06% |
765,749
+523
| +0.1% | +$133K |
|
205
Paycom
PAYC
$9.46B
| $199M | 0.06% |
875,980
-747,100
| -46% | -$153M |
|
206
Ecolab
ECL
$77.6B
| $196M | 0.06% |
991,941
+630
| +0.1% | +$117K |
|
207
CONMED
CNMD
$1.5B
| $194M | 0.06% |
2,270,162
+369,000
| +19% | +$30.3M |
|
208
Cannae Holdings
CNNE
$664M
| $192M | 0.06% |
6,620,000
| – | – |
|
209
Boston Scientific
BSX
$75.4B
| $192M | 0.06% |
4,458,961
-1,917,874
| -30% | -$73.8M |
|
210
Telus
TU
$15.1B
| $191M | 0.06% |
10,330,320
+8,932
| +0.1% | +$165K |
|
211
East-West Bancorp
EWBC
$18.6B
| $190M | 0.06% |
4,057,046
+3,058
| +0.1% | +$146K |
|
212
Automatic Data Processing
ADP
$107B
| $187M | 0.06% |
1,131,887
+253,887
| +29% | +$41.3M |
|
|
ALLK
213
DELISTED
Allakos
ALLK
| $183M | 0.06% |
4,218,788
+26,191
| +0.6% | +$1.07M |
|
214
Kroger
KR
$34.8B
| $183M | 0.06% |
8,412,860
-353,024
| -4% | -$8.59M |
|
215
West Pharmaceutical
WST
$24.5B
| $180M | 0.06% |
1,436,834
+967
| +0.1% | +$114K |
|
|
MGP
216
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $179M | 0.06% |
5,830,700
-67,500
| -1% | -$2.14M |
|
217
Madrigal Pharmaceuticals
MDGL
$12.3B
| $176M | 0.06% |
1,683,262
+18,810
| +1% | +$2.01M |
|
218
Novartis
NVS
$290B
| $174M | 0.06% |
1,902,109
+172,214
| +10% | +$14.6M |
|
219
Dine Brands
DIN
$456M
| $172M | 0.05% |
1,798,937
-125,320
| -7% | -$11.4M |
|
220
Comcast
CMCSA
$92B
| $171M | 0.05% |
4,048,953
+2,513
| +0.1% | +$106K |
|
|
IPHI
221
DELISTED
INPHI CORPORATION
IPHI
| $171M | 0.05% |
3,405,310
-31,038
| -0.9% | -$1.45M |
|
222
LivaNova
LIVN
$4.5B
| $171M | 0.05% |
2,370,699
+1,450,799
| +158% | +$106M |
|
|
TMX
223
DELISTED
Terminix Global Holdings, Inc.
TMX
| $167M | 0.05% |
3,200,250
-282,000
| -8% | -$14.5M |
|
224
Progressive
PGR
$122B
| $160M | 0.05% |
2,001,896
-117,272
| -6% | -$9.07M |
|
225
Webster Financial
WBS
$12.8B
| $159M | 0.05% |
3,331,749
-774,425
| -19% | -$38.6M |
|
Similar funds
Capital Research Global Investors's Q2 2019 Portfolio in Review
As of Q2 2019, Capital Research Global Investors held 443 positions worth $315B, down 0.14% from $315B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Capital Research Global Investors's Q2 2019 filing shows 29 new, 207 increased, 136 reduced and 42 closed positions. Its largest new stake was TC Energy: 30,064,463 shares worth $1.49B. The largest sale was AbbVie, an estimated $2.86B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
- Capital Research Global Investors's largest Q2 2019 buy was TC Energy: 30,064,463 shares worth $1.49B.
- Capital Research Global Investors added most to Constellation Brands in Q2 2019, an estimated $1.47B increase.
- Capital Research Global Investors's biggest Q2 2019 reduction was AbbVie, cutting an estimated $2.86B.
- Capital Research Global Investors fully exited Johnson Controls International in Q2 2019, selling an estimated $403M.
- Capital Research Global Investors's ten largest holdings make up 28% of its $315B portfolio in Q2 2019.
- Capital Research Global Investors opened 29 new positions and closed 42 in Q2 2019.
- Capital Research Global Investors's portfolio value fell 0.14% quarter-over-quarter to $315B.
Based on Capital Research Global Investors's 13F filing for Q2 2019, filed 14 Aug 2019.